528 related articles for article (PubMed ID: 22200330)
21. The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells.
Joshi P; Chakraborti S; Ramirez-Vick JE; Ansari ZA; Shanker V; Chakrabarti P; Singh SP
Colloids Surf B Biointerfaces; 2012 Jun; 95():195-200. PubMed ID: 22445746
[TBL] [Abstract][Full Text] [Related]
22. Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid-Quercetin-Conjugated Silver Nanoparticles.
Al-Serwi RH; Eladl MA; El-Sherbiny M; Saleh MA; Othman G; Alshahrani SM; Alnefaie R; Jan AM; Alnasser SM; Albalawi AE; Mohamed JMM; Menaa F
Molecules; 2023 May; 28(10):. PubMed ID: 37241888
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
Guo M; Que C; Wang C; Liu X; Yan H; Liu K
Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
[TBL] [Abstract][Full Text] [Related]
24. Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities.
Labbozzetta M; Baruchello R; Marchetti P; Gueli MC; Poma P; Notarbartolo M; Simoni D; D'Alessandro N
Chem Biol Interact; 2009 Sep; 181(1):29-36. PubMed ID: 19539615
[TBL] [Abstract][Full Text] [Related]
25. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
Du JZ; Du XJ; Mao CQ; Wang J
J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
Datir SR; Das M; Singh RP; Jain S
Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
[TBL] [Abstract][Full Text] [Related]
27. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells.
Ghaffari M; Dehghan G; Baradaran B; Zarebkohan A; Mansoori B; Soleymani J; Ezzati Nazhad Dolatabadi J; Hamblin MR
Colloids Surf B Biointerfaces; 2020 Apr; 188():110762. PubMed ID: 31911391
[TBL] [Abstract][Full Text] [Related]
28. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
Wei X; Senanayake TH; Bohling A; Vinogradov SV
Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
[TBL] [Abstract][Full Text] [Related]
30. Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin.
Danafar H; Sharafi A; Askarlou S; Manjili HK
Drug Res (Stuttg); 2017 Dec; 67(12):698-704. PubMed ID: 28738425
[TBL] [Abstract][Full Text] [Related]
31. Preparation of Curcumin-Containing α-, β-, and γ-Cyclodextrin/Polyethyleneglycol-Conjugated Gold Multifunctional Nanoparticles and Their in Vitro Cytotoxic Effects on A549 Cells.
Hoshikawa A; Nagira M; Tane M; Fukushige K; Tagami T; Ozeki T
Biol Pharm Bull; 2018; 41(6):908-914. PubMed ID: 29863079
[TBL] [Abstract][Full Text] [Related]
32. [In vitro pharmacodynamic interactions of antitumor effect of the combination of adriamycin and curcumin evaluated by the parameter method and the response surface].
Lü YH; Yang J; Chen JC; Li LJ; Liu HX; Zheng QS
Yao Xue Xue Bao; 2010 Aug; 45(8):1039-42. PubMed ID: 21351592
[TBL] [Abstract][Full Text] [Related]
33. Design and development of water-soluble curcumin conjugates as potential anticancer agents.
Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA
J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470
[TBL] [Abstract][Full Text] [Related]
34. Nuclear penetration of surface functionalized gold nanoparticles.
Gu YJ; Cheng J; Lin CC; Lam YW; Cheng SH; Wong WT
Toxicol Appl Pharmacol; 2009 Jun; 237(2):196-204. PubMed ID: 19328820
[TBL] [Abstract][Full Text] [Related]
35. pH-sensitive micelles based on acid-labile pluronic F68-curcumin conjugates for improved tumor intracellular drug delivery.
Fang XB; Zhang JM; Xie X; Liu D; He CW; Wan JB; Chen MW
Int J Pharm; 2016 Apr; 502(1-2):28-37. PubMed ID: 26784981
[TBL] [Abstract][Full Text] [Related]
36. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and cancer cell cytotoxicity of water-soluble gold(III) substituted tetraarylporphyrin.
Sun L; Chen H; Zhang Z; Yang Q; Tong H; Xu A; Wang C
J Inorg Biochem; 2012 Mar; 108():47-52. PubMed ID: 22265838
[TBL] [Abstract][Full Text] [Related]
38. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
39. Promotion of the anticancer activity of curcumin based on a metal-polyphenol networks delivery system.
Chen Y; Jia D; Wang Q; Sun Y; Rao Z; Lei X; Zhao J; Zeng K; Xu Z; Ming J
Int J Pharm; 2021 Jun; 602():120650. PubMed ID: 33957265
[TBL] [Abstract][Full Text] [Related]
40. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.
Zhang X; Chibli H; Mielke R; Nadeau J
Bioconjug Chem; 2011 Feb; 22(2):235-43. PubMed ID: 21189001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
